9.8 |
78.1 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
4.8 |
14.3 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
4.6 |
13.8 |
GO:0003345 |
proepicardium cell migration involved in pericardium morphogenesis(GO:0003345) |
4.1 |
53.8 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
3.6 |
21.5 |
GO:1904936 |
cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
3.5 |
20.7 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
3.3 |
3.3 |
GO:0097324 |
melanocyte migration(GO:0097324) |
3.2 |
9.7 |
GO:0002302 |
CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
3.2 |
16.0 |
GO:1903215 |
negative regulation of protein targeting to mitochondrion(GO:1903215) |
2.9 |
14.7 |
GO:0042636 |
negative regulation of hair cycle(GO:0042636) negative regulation of hair follicle development(GO:0051799) positive regulation of ovulation(GO:0060279) |
2.9 |
32.1 |
GO:0060159 |
regulation of dopamine receptor signaling pathway(GO:0060159) |
2.9 |
11.5 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
2.7 |
8.2 |
GO:0007521 |
muscle cell fate determination(GO:0007521) cellular response to parathyroid hormone stimulus(GO:0071374) positive regulation of macrophage apoptotic process(GO:2000111) |
2.7 |
40.2 |
GO:1902993 |
positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
2.5 |
27.1 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
2.3 |
21.1 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
2.3 |
6.9 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
2.2 |
11.1 |
GO:0098735 |
positive regulation of the force of heart contraction(GO:0098735) |
2.1 |
8.6 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
2.1 |
16.9 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
2.1 |
6.2 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
2.1 |
12.3 |
GO:0072318 |
clathrin coat disassembly(GO:0072318) |
1.8 |
3.6 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
1.8 |
15.9 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
1.7 |
5.2 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
1.7 |
15.2 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
1.7 |
6.7 |
GO:0021764 |
amygdala development(GO:0021764) |
1.7 |
6.6 |
GO:2000481 |
positive regulation of cAMP-dependent protein kinase activity(GO:2000481) |
1.6 |
21.1 |
GO:1901629 |
regulation of presynaptic membrane organization(GO:1901629) |
1.6 |
9.3 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.6 |
4.7 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
1.6 |
4.7 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
1.5 |
7.5 |
GO:0015692 |
vanadium ion transport(GO:0015676) lead ion transport(GO:0015692) |
1.5 |
7.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
1.4 |
4.3 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
1.4 |
11.2 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
1.4 |
4.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
1.4 |
16.6 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.4 |
34.1 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
1.4 |
8.1 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
1.3 |
5.4 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
1.3 |
1.3 |
GO:0045608 |
inhibition of neuroepithelial cell differentiation(GO:0002085) negative regulation of auditory receptor cell differentiation(GO:0045608) |
1.3 |
10.0 |
GO:0071372 |
cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
1.2 |
11.1 |
GO:0001696 |
gastric acid secretion(GO:0001696) |
1.2 |
3.7 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
1.2 |
8.4 |
GO:0005513 |
detection of calcium ion(GO:0005513) |
1.2 |
48.0 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
1.2 |
3.6 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
1.2 |
24.9 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
1.2 |
4.7 |
GO:0055095 |
lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
1.2 |
4.7 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
1.2 |
3.5 |
GO:0035864 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
1.1 |
4.6 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
1.1 |
4.5 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
1.1 |
13.5 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
1.1 |
9.9 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
1.1 |
4.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
1.1 |
4.4 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
1.1 |
9.7 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
1.1 |
4.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
1.1 |
2.1 |
GO:0097090 |
presynaptic membrane organization(GO:0097090) |
1.0 |
7.2 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
1.0 |
3.0 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.0 |
5.9 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
1.0 |
4.9 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.9 |
2.8 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.9 |
0.9 |
GO:0072553 |
terminal button organization(GO:0072553) |
0.8 |
5.1 |
GO:0046549 |
retinal cone cell development(GO:0046549) |
0.8 |
2.5 |
GO:1903896 |
positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
0.8 |
2.4 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
0.8 |
10.4 |
GO:0070842 |
aggresome assembly(GO:0070842) |
0.8 |
5.5 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.8 |
2.4 |
GO:0070428 |
granuloma formation(GO:0002432) negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) toll-like receptor 5 signaling pathway(GO:0034146) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.8 |
2.3 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
0.8 |
2.3 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
0.7 |
3.0 |
GO:0001550 |
ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.7 |
2.2 |
GO:0045617 |
negative regulation of keratinocyte differentiation(GO:0045617) |
0.7 |
2.9 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
0.7 |
2.2 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
0.7 |
2.2 |
GO:0010838 |
positive regulation of keratinocyte proliferation(GO:0010838) |
0.7 |
11.3 |
GO:0050966 |
detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.7 |
2.1 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
0.7 |
12.4 |
GO:0046069 |
cGMP catabolic process(GO:0046069) |
0.7 |
10.2 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
0.7 |
3.3 |
GO:0048170 |
positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
0.6 |
1.2 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.6 |
8.7 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
0.6 |
5.0 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
0.6 |
2.5 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.6 |
3.6 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
0.6 |
3.0 |
GO:0060690 |
epithelial cell differentiation involved in salivary gland development(GO:0060690) |
0.6 |
1.2 |
GO:1903243 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.6 |
0.6 |
GO:0044830 |
modulation by host of viral RNA genome replication(GO:0044830) |
0.6 |
16.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
0.6 |
2.3 |
GO:0071205 |
protein localization to paranode region of axon(GO:0002175) protein localization to juxtaparanode region of axon(GO:0071205) |
0.6 |
4.5 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
0.6 |
1.7 |
GO:0050925 |
negative regulation of negative chemotaxis(GO:0050925) |
0.5 |
40.1 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
0.5 |
1.6 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
0.5 |
2.7 |
GO:0071294 |
cellular response to zinc ion(GO:0071294) |
0.5 |
2.2 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
0.5 |
1.1 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
0.5 |
4.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
0.5 |
1.1 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.5 |
2.1 |
GO:0044330 |
canonical Wnt signaling pathway involved in positive regulation of wound healing(GO:0044330) lactic acid secretion(GO:0046722) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
0.5 |
0.5 |
GO:0090274 |
positive regulation of somatostatin secretion(GO:0090274) |
0.5 |
2.0 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
0.5 |
2.0 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
0.5 |
5.0 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
0.5 |
1.0 |
GO:2000790 |
regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.5 |
3.5 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
0.5 |
2.0 |
GO:1901301 |
regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.5 |
2.5 |
GO:0035019 |
somatic stem cell population maintenance(GO:0035019) |
0.5 |
1.5 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
0.5 |
2.4 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
0.5 |
4.3 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
0.5 |
3.3 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
0.5 |
3.3 |
GO:0086018 |
SA node cell action potential(GO:0086015) SA node cell to atrial cardiac muscle cell signalling(GO:0086018) SA node cell to atrial cardiac muscle cell communication(GO:0086070) |
0.5 |
1.4 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.4 |
1.3 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.4 |
2.2 |
GO:0048245 |
eosinophil chemotaxis(GO:0048245) |
0.4 |
0.4 |
GO:0007525 |
somatic muscle development(GO:0007525) |
0.4 |
1.3 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.4 |
3.9 |
GO:0007379 |
segment specification(GO:0007379) |
0.4 |
1.3 |
GO:0001570 |
vasculogenesis(GO:0001570) |
0.4 |
5.6 |
GO:0061339 |
establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.4 |
2.6 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
0.4 |
10.6 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.4 |
2.1 |
GO:0003105 |
negative regulation of glomerular filtration(GO:0003105) |
0.4 |
2.0 |
GO:0090091 |
positive regulation of extracellular matrix disassembly(GO:0090091) |
0.4 |
3.3 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
0.4 |
2.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
0.4 |
2.0 |
GO:1901843 |
positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.4 |
1.2 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
0.4 |
4.0 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
0.4 |
1.2 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
0.4 |
1.9 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
0.4 |
5.8 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
0.4 |
3.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
0.4 |
1.9 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.4 |
1.9 |
GO:0042997 |
negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.4 |
1.5 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
0.4 |
1.8 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
0.4 |
3.9 |
GO:0060539 |
diaphragm development(GO:0060539) |
0.3 |
1.4 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
0.3 |
1.0 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
0.3 |
2.4 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
0.3 |
3.4 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.3 |
1.6 |
GO:2000301 |
negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.3 |
0.3 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
0.3 |
1.0 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 |
2.3 |
GO:0043497 |
regulation of protein heterodimerization activity(GO:0043497) |
0.3 |
0.6 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.3 |
1.0 |
GO:0031117 |
positive regulation of microtubule depolymerization(GO:0031117) |
0.3 |
1.9 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.3 |
1.0 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.3 |
3.4 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
0.3 |
24.2 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
0.3 |
5.1 |
GO:0007097 |
nuclear migration(GO:0007097) |
0.3 |
0.9 |
GO:0002331 |
pre-B cell allelic exclusion(GO:0002331) |
0.3 |
1.5 |
GO:0030242 |
pexophagy(GO:0030242) |
0.3 |
7.1 |
GO:0097576 |
vacuole fusion(GO:0097576) |
0.3 |
2.1 |
GO:0007296 |
vitellogenesis(GO:0007296) |
0.3 |
0.9 |
GO:2000508 |
regulation of dendritic cell chemotaxis(GO:2000508) positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.3 |
0.9 |
GO:0042264 |
peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.3 |
0.6 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
0.3 |
1.2 |
GO:2000302 |
positive regulation of synaptic vesicle exocytosis(GO:2000302) |
0.3 |
1.7 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
0.3 |
1.1 |
GO:0045955 |
negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.3 |
0.6 |
GO:0035434 |
copper ion transmembrane transport(GO:0035434) |
0.3 |
5.2 |
GO:0010603 |
regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.3 |
1.1 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
0.3 |
0.5 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
0.3 |
16.6 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.3 |
14.3 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
0.3 |
1.0 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
0.3 |
0.5 |
GO:0021557 |
oculomotor nerve development(GO:0021557) |
0.3 |
2.3 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.2 |
2.7 |
GO:0001919 |
regulation of receptor recycling(GO:0001919) |
0.2 |
1.0 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
0.2 |
2.0 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 |
1.5 |
GO:0060013 |
righting reflex(GO:0060013) |
0.2 |
6.2 |
GO:0051642 |
centrosome localization(GO:0051642) |
0.2 |
3.2 |
GO:0030238 |
male sex determination(GO:0030238) |
0.2 |
4.1 |
GO:0010758 |
regulation of macrophage chemotaxis(GO:0010758) |
0.2 |
8.9 |
GO:0043666 |
regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.2 |
2.6 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 |
0.5 |
GO:2000065 |
negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.2 |
0.5 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
0.2 |
1.9 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.2 |
3.5 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
0.2 |
0.9 |
GO:0046898 |
response to cycloheximide(GO:0046898) |
0.2 |
1.4 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
0.2 |
1.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
0.2 |
1.1 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
0.2 |
5.7 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 |
0.9 |
GO:0036438 |
maintenance of lens transparency(GO:0036438) |
0.2 |
1.5 |
GO:0001842 |
neural fold formation(GO:0001842) |
0.2 |
3.4 |
GO:0060218 |
hematopoietic stem cell differentiation(GO:0060218) |
0.2 |
1.3 |
GO:0071442 |
positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.2 |
1.5 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
0.2 |
4.0 |
GO:0045116 |
protein neddylation(GO:0045116) |
0.2 |
1.0 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
0.2 |
0.6 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
0.2 |
1.7 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
0.2 |
2.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
0.2 |
0.4 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.2 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 |
0.8 |
GO:1903898 |
positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 |
1.6 |
GO:0031937 |
positive regulation of chromatin silencing(GO:0031937) |
0.2 |
4.9 |
GO:0014065 |
phosphatidylinositol 3-kinase signaling(GO:0014065) |
0.2 |
2.7 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
0.2 |
2.7 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
0.2 |
1.5 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
0.2 |
5.7 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.2 |
1.5 |
GO:0090043 |
regulation of tubulin deacetylation(GO:0090043) |
0.2 |
1.5 |
GO:0035871 |
protein K11-linked deubiquitination(GO:0035871) |
0.2 |
0.4 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
0.2 |
0.8 |
GO:0010825 |
positive regulation of centrosome duplication(GO:0010825) |
0.2 |
1.1 |
GO:0034587 |
piRNA metabolic process(GO:0034587) |
0.2 |
0.6 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
0.2 |
0.9 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 |
0.4 |
GO:0035898 |
parathyroid hormone secretion(GO:0035898) |
0.2 |
0.6 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
0.2 |
1.6 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
0.2 |
5.6 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
0.2 |
0.5 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
0.2 |
1.4 |
GO:0019227 |
neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 |
0.7 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
0.2 |
1.1 |
GO:0000056 |
ribosomal small subunit export from nucleus(GO:0000056) |
0.2 |
6.5 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
0.2 |
8.7 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
0.2 |
1.8 |
GO:0030220 |
platelet formation(GO:0030220) |
0.2 |
0.8 |
GO:0032782 |
bile acid secretion(GO:0032782) |
0.2 |
1.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.2 |
0.8 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
0.2 |
0.5 |
GO:0031622 |
positive regulation of fever generation(GO:0031622) negative regulation of action potential(GO:0045759) |
0.2 |
0.3 |
GO:0045472 |
response to ether(GO:0045472) |
0.2 |
1.5 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
0.1 |
1.3 |
GO:0098743 |
cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 |
0.9 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
0.1 |
0.3 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 |
0.7 |
GO:0007197 |
adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
0.1 |
2.6 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
0.1 |
5.5 |
GO:0046627 |
negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 |
0.6 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
0.1 |
1.5 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.1 |
0.8 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.1 |
1.5 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
0.1 |
1.2 |
GO:0051292 |
nuclear pore complex assembly(GO:0051292) |
0.1 |
0.4 |
GO:0097623 |
potassium ion export across plasma membrane(GO:0097623) |
0.1 |
0.4 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
0.1 |
2.3 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
0.1 |
3.1 |
GO:0007212 |
dopamine receptor signaling pathway(GO:0007212) |
0.1 |
2.0 |
GO:0014912 |
negative regulation of smooth muscle cell migration(GO:0014912) |
0.1 |
0.4 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
0.1 |
2.0 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
0.1 |
0.6 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.1 |
0.4 |
GO:0021649 |
vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
0.1 |
0.9 |
GO:0095500 |
acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.1 |
0.7 |
GO:0031424 |
keratinization(GO:0031424) |
0.1 |
1.2 |
GO:0007157 |
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.1 |
0.6 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
0.1 |
0.7 |
GO:0007016 |
cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.1 |
4.8 |
GO:0046580 |
negative regulation of Ras protein signal transduction(GO:0046580) |
0.1 |
0.3 |
GO:0044028 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.1 |
8.4 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
0.1 |
0.2 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 |
0.3 |
GO:0048149 |
behavioral response to ethanol(GO:0048149) |
0.1 |
0.6 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 |
1.0 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
0.1 |
0.4 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
0.1 |
0.8 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
0.1 |
3.2 |
GO:0045773 |
positive regulation of axon extension(GO:0045773) |
0.1 |
0.3 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 |
3.6 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
0.1 |
0.1 |
GO:0010873 |
positive regulation of cholesterol esterification(GO:0010873) |
0.1 |
0.4 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
0.1 |
0.3 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 |
1.0 |
GO:0010921 |
regulation of phosphatase activity(GO:0010921) |
0.1 |
2.6 |
GO:0006491 |
N-glycan processing(GO:0006491) |
0.1 |
6.9 |
GO:0031532 |
actin cytoskeleton reorganization(GO:0031532) |
0.1 |
0.1 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
0.1 |
1.0 |
GO:0043374 |
CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.1 |
1.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
0.1 |
1.3 |
GO:0006107 |
oxaloacetate metabolic process(GO:0006107) |
0.1 |
0.9 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
0.1 |
0.4 |
GO:0006780 |
uroporphyrinogen III biosynthetic process(GO:0006780) |
0.1 |
0.4 |
GO:0017085 |
response to insecticide(GO:0017085) |
0.1 |
1.1 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
0.1 |
0.7 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
0.1 |
2.0 |
GO:0021952 |
central nervous system projection neuron axonogenesis(GO:0021952) |
0.1 |
0.6 |
GO:1902043 |
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 |
0.7 |
GO:0032231 |
regulation of actin filament bundle assembly(GO:0032231) positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 |
0.4 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
0.1 |
0.8 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 |
0.2 |
GO:0060011 |
Sertoli cell proliferation(GO:0060011) |
0.1 |
1.5 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 |
0.7 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
0.1 |
0.2 |
GO:1904263 |
positive regulation of TORC1 signaling(GO:1904263) |
0.1 |
0.3 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 |
0.1 |
GO:0097475 |
motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 |
8.9 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
0.1 |
3.1 |
GO:0010761 |
fibroblast migration(GO:0010761) |
0.1 |
3.8 |
GO:0002224 |
toll-like receptor signaling pathway(GO:0002224) |
0.1 |
0.8 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
0.1 |
5.2 |
GO:0030048 |
actin filament-based movement(GO:0030048) |
0.1 |
0.5 |
GO:1990564 |
protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.1 |
0.2 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 |
3.2 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
0.1 |
1.6 |
GO:0016180 |
snRNA processing(GO:0016180) |
0.1 |
1.9 |
GO:0001895 |
retina homeostasis(GO:0001895) |
0.1 |
0.2 |
GO:0090310 |
negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 |
1.0 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 |
0.6 |
GO:0006449 |
regulation of translational termination(GO:0006449) |
0.1 |
1.2 |
GO:0021692 |
cerebellar Purkinje cell layer morphogenesis(GO:0021692) |
0.1 |
0.4 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
0.1 |
0.6 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
0.1 |
0.9 |
GO:0006614 |
SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 |
0.9 |
GO:0010506 |
regulation of autophagy(GO:0010506) |
0.1 |
11.6 |
GO:0042384 |
cilium assembly(GO:0042384) |
0.1 |
0.8 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 |
0.4 |
GO:0035886 |
vascular smooth muscle cell differentiation(GO:0035886) |
0.1 |
0.7 |
GO:0014823 |
response to activity(GO:0014823) |
0.1 |
0.3 |
GO:0021942 |
radial glia guided migration of Purkinje cell(GO:0021942) |
0.1 |
0.3 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
0.1 |
0.3 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.1 |
0.9 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
0.1 |
1.4 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
0.1 |
0.1 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
0.1 |
4.5 |
GO:0019722 |
calcium-mediated signaling(GO:0019722) |
0.1 |
0.9 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
0.1 |
0.6 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
0.1 |
0.8 |
GO:0032402 |
melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.1 |
1.7 |
GO:0046579 |
positive regulation of Ras protein signal transduction(GO:0046579) |
0.1 |
1.2 |
GO:0030307 |
positive regulation of cell growth(GO:0030307) |
0.1 |
0.4 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 |
1.2 |
GO:0006110 |
regulation of glycolytic process(GO:0006110) |
0.1 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 |
0.4 |
GO:0072583 |
clathrin-mediated endocytosis(GO:0072583) |
0.1 |
0.2 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 |
0.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
0.1 |
2.5 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
0.1 |
0.5 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 |
0.5 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
0.1 |
1.1 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
0.1 |
0.4 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
0.1 |
1.1 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
0.1 |
8.9 |
GO:0006417 |
regulation of translation(GO:0006417) |
0.0 |
0.4 |
GO:0080111 |
DNA demethylation(GO:0080111) |
0.0 |
0.3 |
GO:1902916 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) positive regulation of protein polyubiquitination(GO:1902916) |
0.0 |
0.8 |
GO:0051457 |
maintenance of protein location in nucleus(GO:0051457) |
0.0 |
0.2 |
GO:0071476 |
hypotonic response(GO:0006971) cellular hypotonic response(GO:0071476) |
0.0 |
5.6 |
GO:0007266 |
Rho protein signal transduction(GO:0007266) |
0.0 |
0.3 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
0.0 |
0.1 |
GO:0072604 |
interleukin-6 secretion(GO:0072604) |
0.0 |
1.5 |
GO:0000462 |
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 |
0.4 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) male meiosis I(GO:0007141) |
0.0 |
1.8 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
0.0 |
1.2 |
GO:1903747 |
regulation of protein targeting to mitochondrion(GO:1903214) regulation of establishment of protein localization to mitochondrion(GO:1903747) |
0.0 |
0.3 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 |
0.7 |
GO:1902230 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.0 |
0.4 |
GO:0032091 |
negative regulation of protein binding(GO:0032091) |
0.0 |
1.7 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
0.0 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 |
1.2 |
GO:0016358 |
dendrite development(GO:0016358) |
0.0 |
0.3 |
GO:0046036 |
GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) lactation(GO:0007595) CTP metabolic process(GO:0046036) |
0.0 |
0.8 |
GO:0007520 |
myoblast fusion(GO:0007520) |
0.0 |
0.6 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
0.0 |
0.1 |
GO:0050957 |
equilibrioception(GO:0050957) |
0.0 |
0.2 |
GO:0032196 |
transposition(GO:0032196) |
0.0 |
0.6 |
GO:0000245 |
spliceosomal complex assembly(GO:0000245) |
0.0 |
0.8 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
0.0 |
0.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
0.0 |
0.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
0.0 |
0.2 |
GO:0051152 |
positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 |
0.5 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
0.0 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
0.0 |
0.1 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
0.0 |
0.6 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
0.0 |
0.7 |
GO:0045806 |
negative regulation of endocytosis(GO:0045806) |
0.0 |
0.1 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 |
0.2 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 |
0.3 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
0.0 |
0.7 |
GO:1901998 |
toxin transport(GO:1901998) |
0.0 |
0.3 |
GO:0097186 |
amelogenesis(GO:0097186) |
0.0 |
0.7 |
GO:0046324 |
regulation of glucose import(GO:0046324) |
0.0 |
0.2 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 |
0.0 |
GO:0072592 |
oxygen metabolic process(GO:0072592) |
0.0 |
0.4 |
GO:0046329 |
negative regulation of JNK cascade(GO:0046329) |
0.0 |
0.5 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
0.0 |
0.2 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
0.0 |
0.2 |
GO:0021670 |
lateral ventricle development(GO:0021670) |
0.0 |
0.7 |
GO:0032527 |
protein exit from endoplasmic reticulum(GO:0032527) |
0.0 |
0.2 |
GO:0009409 |
response to cold(GO:0009409) |
0.0 |
0.1 |
GO:0006968 |
cellular defense response(GO:0006968) |
0.0 |
0.8 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.0 |
0.1 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
0.0 |
0.2 |
GO:0070301 |
cellular response to hydrogen peroxide(GO:0070301) |
0.0 |
0.1 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
0.0 |
0.2 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
0.0 |
0.1 |
GO:0050982 |
detection of mechanical stimulus(GO:0050982) |
0.0 |
0.4 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
0.0 |
0.1 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 |
0.2 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
0.0 |
0.2 |
GO:0006465 |
signal peptide processing(GO:0006465) |
0.0 |
0.2 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 |
0.2 |
GO:0090200 |
positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 |
0.3 |
GO:0010951 |
negative regulation of endopeptidase activity(GO:0010951) |
0.0 |
0.1 |
GO:0030490 |
maturation of SSU-rRNA(GO:0030490) |
0.0 |
0.2 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
0.0 |
0.4 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
0.0 |
0.0 |
GO:0051030 |
snRNA transport(GO:0051030) |
0.0 |
0.1 |
GO:0061365 |
intestinal cholesterol absorption(GO:0030299) lipid digestion(GO:0044241) positive regulation of triglyceride lipase activity(GO:0061365) |
0.0 |
0.2 |
GO:0043248 |
proteasome assembly(GO:0043248) |